| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2010 3rd Quarter - Report |
DLA PIPER LLP (US) | MEDICINES COMPANY | $400,000 | |
| 2010 2nd Quarter - Report |
DLA PIPER LLP (US) | MEDICINES COMPANY | $610,000 | |
| 2010 2nd Quarter - Termination |
DLA PIPER LLP (US) | PREMIER CHEMICALS, LLC | $20,000 | |
| 2010 2nd Quarter - Report |
DLA PIPER LLP (US) | CAPE WIND ASSOCIATES LLC | $30,000 | |
| 2010 1st Quarter - Report |
DLA PIPER LLP (US) | MEDICINES COMPANY | $730,000 | |
| 2010 1st Quarter - Report |
DLA PIPER LLP (US) | CAPE WIND ASSOCIATES LLC | $30,000 | |
| 2010 1st Quarter - Report |
DLA PIPER LLP (US) | PREMIER CHEMICALS, LLC | $20,000 | |
| 2009 4th Quarter - Report |
DLA PIPER LLP (US) | PREMIER CHEMICALS, LLC | $90,000 | |
| 2009 4th Quarter - Report |
DLA PIPER LLP (US) | MEDICINES COMPANY | $600,000 | |
| 2009 Registration |
DLA PIPER LLP (US) | PREMIER CHEMICALS, LLC | — |